GG 931
Pill imprint GG 931 has been identified as Orphenadrine citrate extended-release 100 mg.
Orphenadrine is used in the treatment of muscle spasm; migraine and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy.
Orphenadrine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Orphenadrine citrate extended-release Images
- Imprint:
-
GG 931
- Strength:
- 100 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 52152-0340
| NDC Code | Manufacturer / Repackager |
|---|---|
| 43386-0480 | Gavis Pharmaceuticals |
| 55045-1325 | Dispensing Solutions Inc. (repackager) |
| 57866-7601 | Direct Dispensing Inc (repackager) |
| 10544-0359 | Blenheim Pharmacal Inc (repackager) |
Note: Inactive ingredients may vary.
Submitted by: pertalo
Advertisement
More Orphenadrine Citrate Extended-Release resources
- Orphenadrine (Wolters Kluwer)
- Orphenadrine Extended-Release Tablets (Wolters Kluwer)
- orphenadrine (Cerner Multum)
- orphenadrine (Micromedex) - Includes Dosage Information
- orphenadrine Injection (Micromedex) - Includes Dosage Information
- Orphenadrine Citrate (AHFS DI)
- Orphenadrine Extended Release Tablets (FDA)
- Orphenadrine Injection (FDA)
- Orphenadrine Citrate (Wolters Kluwer)
Search Again
